- Report
- December 2023
- 52 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- November 2024
- 111 Pages
Global
From €4171EUR$4,650USD£3,566GBP
- Report
- March 2025
- 154 Pages
Global
From €4171EUR$4,650USD£3,566GBP
- Report
- August 2024
- 100 Pages
Global
From €4171EUR$4,650USD£3,566GBP
- Report
- August 2025
- 187 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 199 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- February 2025
- 454 Pages
Global
From €4305EUR$4,799USD£3,680GBP
- Report
- April 2025
- 200 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- March 2025
- 175 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- July 2024
- 339 Pages
Global
From €4485EUR$5,000USD£3,834GBP
- Report
- September 2024
- 323 Pages
Global
From €4485EUR$5,000USD£3,834GBP
- Report
- June 2023
- 340 Pages
Global
From €4485EUR$5,000USD£3,834GBP
- Report
- February 2024
- 115 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- February 2024
- 187 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- February 2021
Global
From €3992EUR$4,450USD£3,413GBP
- Report
- January 2023
- 295 Pages
Global
From €3588EUR$4,000USD£3,068GBP
- Report
- July 2024
- 100 Pages
Global
From €3364EUR$3,750USD£2,876GBP
- Report
- September 2024
- 192 Pages
Global
From €4171EUR$4,650USD£3,566GBP
- Report
- July 2024
- 150 Pages
Global
From €3364EUR$3,750USD£2,876GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more